Search

Your search keyword '"Inactivated vaccine"' showing total 3,459 results

Search Constraints

Start Over You searched for: Descriptor "Inactivated vaccine" Remove constraint Descriptor: "Inactivated vaccine"
3,459 results on '"Inactivated vaccine"'

Search Results

1. Safety observation of COVID-19 inactivated vaccine in immature mice.

2. The immunoadjuvant effects of interleukin-8 on Aeromonas veronii inactivated vaccine in largemouth bass (Micropterus salmoides).

3. Effectiveness of inactivated COVID-19 vaccines in preventing COVID-19-related hospitalization during the Omicron BF.7-predominant epidemic wave in Beijing, China: a cohort study.

4. 接种三剂新冠病毒灭活疫苗后抗新冠病毒抗体动态变化研究.

5. Comparing the immunogenicity of COVID-19 infection and vaccination in pregnant women as measured by anti-S IgG.

6. Evaluation of the Effect of mRNA and Inactivated SARS-CoV-2 Vaccines on the Levels of Cytokines IL-2, IFN-γ, and Anti-RBD Spike SARS-CoV-2 Antibodies in People Living with HIV (PLHIV).

7. First Trial of a Novel Caseous Lymphadenitis Inactivated Vaccine in South Korea: Experimental Evaluation across Various Animal Models.

8. A mathematical model simulating the adaptive immune response in various vaccines and vaccination strategies

9. Use of 'ARRIAH-AviFluVac' vaccine in turkeys, geese and ducks

10. Effectiveness of inactivated COVID-19 vaccines in preventing COVID-19-related hospitalization during the Omicron BF.7-predominant epidemic wave in Beijing, China: a cohort study

11. Comparing the immunogenicity of COVID-19 infection and vaccination in pregnant women as measured by anti-S IgG

12. Efficacy of the COVID-19 vaccination in patients with asymptomatic or mild illness during the Omicron epidemic in Guangzhou: a multi-centre retrospective cohort study.

13. Synergistic Effect of Co-Administered SARS-CoV-2 Vaccines Improves Immune Responses in BALB/c Mice: A Preliminary Study

14. Immunogenicity of an Inactivated Senecavirus A Vaccine with a Contemporary Brazilian Strain in Mice.

15. Water‐in‐oil adjuvant challenges in fish vaccination: An experimental inactivated adjuvanted vaccine against betanodavirus infection in Senegalese sole.

16. Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side Effect.

17. The Immunogenic Potential of an Inactivated Vaccine Candidate against Ornithobacterium Rhinotracheale in SPF Chicken.

18. Effect of Formulation (particle size) of inactivated AI+ND vaccine on Stability and Immunogenicity in SPF and Broiler Chickens.

19. Efficacy, safety, and immunogenicity of SARS-CoV-2 mRNA vaccine (Omicron BA.5) LVRNA012: a randomized, double-blind, placebo-controlled phase 3 trial.

20. Effectiveness of inactivated and mRNA COVID-19 vaccines on sperm parameters.

21. Synergistic Effect of Co-Administered SARS-CoV-2 Vaccines Improves Immune Responses in BALB/c Mice: A Preliminary Study.

22. Omicron breakthrough infections after triple‐dose inactivated COVID‐19 vaccination: A comprehensive analysis of antibody and T‐cell responses.

23. Field Trials of Live and Inactivated Camelpox Vaccines in Kazakhstan.

24. Heterogeneity of SARS-CoV-2 immune responses after the nationwide Omicron wave in China

25. Investigation of the epidemiology, pathogenicity and immunogenicity of Bordetella bronchiseptica isolated from cats and dogs in China from 2021 to 2023

26. Serological evaluation and antibody prediction model for inactivated COVID-19 vaccination in school children

27. Advantages of COVID-19 vaccine in the T cell immune response

28. Inactivated Toxoplasma gondii nanovaccine boosts T-cell memory response in a seropositive yellow-footed rock wallaby (Petrogale xanthopus) – A case report from Copenhagen Zoo

29. Immunogenicity and protective efficacy of inactivated coxsackievirus B4 viral particles

30. Investigation of the epidemiology, pathogenicity and immunogenicity of Bordetella bronchiseptica isolated from cats and dogs in China from 2021 to 2023.

31. Development and evaluation of inactivated vaccines incorporating a novel Senecavirus A strain-based Immunogen and various adjuvants in mice.

32. Safety and neutralization antibody levels of inactivated SARS-CoV-2 vaccine in adult patients with Myasthenia Gravis: a prospective observational cohort study.

33. Observational analysis of the immunogenicity and safety of various types of spinal muscular atrophy vaccines.

34. Comparative single‐cell RNA sequencing analysis of immune response to inactivated vaccine and natural SARS‐CoV‐2 infection.

35. Vaccine Development for Severe Fever with Thrombocytopenia Syndrome Virus in Dogs.

36. Prenatal maternal inactivated COVID-19 vaccination: the maternal and neonatal outcomes, a retrospective cohort study.

37. Approaches of dengue control: vaccine strategies and future aspects.

38. Does the immune stimulant Amplimune® modulate humoral and cytokine responses to commercial bovine respiratory disease vaccines in cattle?

39. Protective Activity of Inactivated Rabies Vaccine Using Flagellin-Based Adjuvant.

40. A Cost Analysis of COVID-19 Vaccination: A Comparison between mRNA-based and Inactivated Virus Vaccines.

41. Adverse events following COVID-19 vaccination: An online survey.

42. Effectiveness of Sinopharm's BBIBP-CorV Booster Vaccination against COVID-19-Related Severe and Critical Cases and Deaths in Morocco during the Omicron Wave.

43. Inactivated whole virion vaccine protects K18‐hACE2 Tg mice against the Omicron SARS‐CoV‐2 variant via cross‐reactive T cells and nonneutralizing antibody responses.

44. Impfungen bei chronisch-entzündlichen Erkrankungen und unter Immunsuppression.

45. Efficacy and Safety of an Inactivated Novel Variant Infectious Bursal Disease Virus in Broiler Chickens.

46. Clinical characteristics of COVID-19 clusters in three schools in Beijing, China: A retrospective study

47. Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARSCoV-2: a local study in Macao.

48. Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up.

49. H9N2 AIV灭活疫苗免疫SPF鸡攻毒后肺组织免疫相关基因表达变化研究.

50. Altered liver function test after Covid‐19 vaccines: A retrospective control group study.

Catalog

Books, media, physical & digital resources